Cargando…

Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver

Diffusion-weighted imaging (DWI) is an important diagnostic tool in the assessment of focal liver lesions and diffuse liver diseases such as cirrhosis and fibrosis. Quantitative DWI parameters such as molecular diffusion, microperfusion and their fractions, are known to be affected when hepatic fat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijkstra, Hildebrand, Handayani, Astri, Kappert, Peter, Oudkerk, Matthijs, Sijens, Paul E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913701/
https://www.ncbi.nlm.nih.gov/pubmed/24505333
http://dx.doi.org/10.1371/journal.pone.0087926
_version_ 1782302275081863168
author Dijkstra, Hildebrand
Handayani, Astri
Kappert, Peter
Oudkerk, Matthijs
Sijens, Paul E.
author_facet Dijkstra, Hildebrand
Handayani, Astri
Kappert, Peter
Oudkerk, Matthijs
Sijens, Paul E.
author_sort Dijkstra, Hildebrand
collection PubMed
description Diffusion-weighted imaging (DWI) is an important diagnostic tool in the assessment of focal liver lesions and diffuse liver diseases such as cirrhosis and fibrosis. Quantitative DWI parameters such as molecular diffusion, microperfusion and their fractions, are known to be affected when hepatic fat fractions (HFF) are higher than 5.5% (steatosis). However, less is known about the effect on DWI for HFF in the normal non-steatotic range below 5.5%, which can be found in a large part of the population. The aim of this study was therefore to evaluate the diagnostic implications of non-steatotic HFF on quantitative DWI parameters in eight liver segments. For this purpose, eleven healthy volunteers (2 men, mean-age 31.0) were prospectively examined with DWI and three series of in-/out-of-phase dual-echo spoiled gradient-recalled MRI sequences to obtain the HFF and T(2)*. DWI data were analyzed using the intravoxel incoherent motion (IVIM) model. Four circular regions (ø22.3 mm) were drawn in each of eight liver segments and averaged. Measurements were divided in group 1 (HFF≤2.75%), group 2 (2.75< HFF ≤5.5%) and group 3 (HFF>5.5%). DWI parameters and T(2)* were compared between the three groups and between the segments. It was observed that the molecular diffusion (0.85, 0.72 and 0.49 ×10(−3 )mm(2)/s) and T(2)* (32.2, 27.2 and 21.0 ms) differed significantly between the three groups of increasing HFF (2.18, 3.50 and 19.91%). Microperfusion and its fraction remained similar for different HFF. Correlations with HFF were observed for the molecular diffusion (r = −0.514, p<0.001) and T(2)* (−0.714, p<0.001). Similar results were obtained for the majority of individual liver segments. It was concluded that fat significantly decreases molecular diffusion in the liver, also in absence of steatosis (HFF≤5.5%). Also, it was confirmed that fat influences T(2)*. Determination of HFF prior to quantitative DWI is therefore crucial.
format Online
Article
Text
id pubmed-3913701
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39137012014-02-06 Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver Dijkstra, Hildebrand Handayani, Astri Kappert, Peter Oudkerk, Matthijs Sijens, Paul E. PLoS One Research Article Diffusion-weighted imaging (DWI) is an important diagnostic tool in the assessment of focal liver lesions and diffuse liver diseases such as cirrhosis and fibrosis. Quantitative DWI parameters such as molecular diffusion, microperfusion and their fractions, are known to be affected when hepatic fat fractions (HFF) are higher than 5.5% (steatosis). However, less is known about the effect on DWI for HFF in the normal non-steatotic range below 5.5%, which can be found in a large part of the population. The aim of this study was therefore to evaluate the diagnostic implications of non-steatotic HFF on quantitative DWI parameters in eight liver segments. For this purpose, eleven healthy volunteers (2 men, mean-age 31.0) were prospectively examined with DWI and three series of in-/out-of-phase dual-echo spoiled gradient-recalled MRI sequences to obtain the HFF and T(2)*. DWI data were analyzed using the intravoxel incoherent motion (IVIM) model. Four circular regions (ø22.3 mm) were drawn in each of eight liver segments and averaged. Measurements were divided in group 1 (HFF≤2.75%), group 2 (2.75< HFF ≤5.5%) and group 3 (HFF>5.5%). DWI parameters and T(2)* were compared between the three groups and between the segments. It was observed that the molecular diffusion (0.85, 0.72 and 0.49 ×10(−3 )mm(2)/s) and T(2)* (32.2, 27.2 and 21.0 ms) differed significantly between the three groups of increasing HFF (2.18, 3.50 and 19.91%). Microperfusion and its fraction remained similar for different HFF. Correlations with HFF were observed for the molecular diffusion (r = −0.514, p<0.001) and T(2)* (−0.714, p<0.001). Similar results were obtained for the majority of individual liver segments. It was concluded that fat significantly decreases molecular diffusion in the liver, also in absence of steatosis (HFF≤5.5%). Also, it was confirmed that fat influences T(2)*. Determination of HFF prior to quantitative DWI is therefore crucial. Public Library of Science 2014-02-04 /pmc/articles/PMC3913701/ /pubmed/24505333 http://dx.doi.org/10.1371/journal.pone.0087926 Text en © 2014 Dijkstra et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Dijkstra, Hildebrand
Handayani, Astri
Kappert, Peter
Oudkerk, Matthijs
Sijens, Paul E.
Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver
title Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver
title_full Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver
title_fullStr Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver
title_full_unstemmed Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver
title_short Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver
title_sort clinical implications of non-steatotic hepatic fat fractions on quantitative diffusion-weighted imaging of the liver
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913701/
https://www.ncbi.nlm.nih.gov/pubmed/24505333
http://dx.doi.org/10.1371/journal.pone.0087926
work_keys_str_mv AT dijkstrahildebrand clinicalimplicationsofnonsteatotichepaticfatfractionsonquantitativediffusionweightedimagingoftheliver
AT handayaniastri clinicalimplicationsofnonsteatotichepaticfatfractionsonquantitativediffusionweightedimagingoftheliver
AT kappertpeter clinicalimplicationsofnonsteatotichepaticfatfractionsonquantitativediffusionweightedimagingoftheliver
AT oudkerkmatthijs clinicalimplicationsofnonsteatotichepaticfatfractionsonquantitativediffusionweightedimagingoftheliver
AT sijenspaule clinicalimplicationsofnonsteatotichepaticfatfractionsonquantitativediffusionweightedimagingoftheliver